<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Amarantus Bioscience Holdings Inc — News on 6ix</title>
    <link>https://6ix.com/company/amarantus-bioscience-holdings-inc</link>
    <description>Latest news and press releases for Amarantus Bioscience Holdings Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 27 Apr 2022 11:30:30 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/amarantus-bioscience-holdings-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683545af78dffbe2df0e2a84.webp</url>
      <title>Amarantus Bioscience Holdings Inc</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc</link>
    </image>
    <item>
      <title>Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/amarantus-signs-non-binding-term-sheet-to-divest-cutanogen-corporation-in-exchange-for-the-extinguishment-of-potential-dollar21m-in-liabilities</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/amarantus-signs-non-binding-term-sheet-to-divest-cutanogen-corporation-in-exchange-for-the-extinguishment-of-potential-dollar21m-in-liabilities</guid>
      <pubDate>Wed, 27 Apr 2022 11:30:30 GMT</pubDate>
      <description>Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities.</description>
    </item>
    <item>
      <title>Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MOTO+PARA’s National Mobile CLIA Lab Partner Integrated Health</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-enters-into-exclusive-covid-19-testing-supply-agreement-with-motoparas-national-mobile-clia-lab-partner-integrated-health</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-enters-into-exclusive-covid-19-testing-supply-agreement-with-motoparas-national-mobile-clia-lab-partner-integrated-health</guid>
      <pubDate>Wed, 07 Oct 2020 11:02:25 GMT</pubDate>
      <description>Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MOTO+PARA’s National Mobile CLIA Lab Partner Integrated Health.</description>
    </item>
    <item>
      <title>Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-enters-into-covid-19-pcr-testing-implementation-and-equipment-financing-partnership-with-aid-genomics</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-enters-into-covid-19-pcr-testing-implementation-and-equipment-financing-partnership-with-aid-genomics</guid>
      <pubDate>Fri, 25 Sep 2020 11:40:41 GMT</pubDate>
      <description>Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics.</description>
    </item>
    <item>
      <title>Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment &amp; Supplies with Wisconsin-based Laboratory to $47.5 Million</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-expands-existing-contract-for-covid-19-pcr-testing-equipment-and-supplies-with-wisconsin-based-laboratory-to-dollar475-million</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-expands-existing-contract-for-covid-19-pcr-testing-equipment-and-supplies-with-wisconsin-based-laboratory-to-dollar475-million</guid>
      <pubDate>Tue, 22 Sep 2020 13:01:41 GMT</pubDate>
      <description>Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment &amp; Supplies with Wisconsin-based Laboratory to $47.5 Million.</description>
    </item>
    <item>
      <title>Todos Medical CEO Releases Letter to Shareholders</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-ceo-releases-letter-to-shareholders</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-ceo-releases-letter-to-shareholders</guid>
      <pubDate>Fri, 18 Sep 2020 14:06:11 GMT</pubDate>
      <description>Todos Medical CEO Releases Letter to Shareholders.</description>
    </item>
    <item>
      <title>3CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Between Todos Medical and NLC Pharma</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/3cl-protease-inhibitor-nlc-001-added-to-covid-19-focused-joint-venture-between-todos-medical-and-nlc-pharma</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/3cl-protease-inhibitor-nlc-001-added-to-covid-19-focused-joint-venture-between-todos-medical-and-nlc-pharma</guid>
      <pubDate>Thu, 17 Sep 2020 13:33:42 GMT</pubDate>
      <description>3CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Between Todos Medical and NLC Pharma.</description>
    </item>
    <item>
      <title>Todos Medical Expands Partnership with Care G.B. Plus for Proprietary TBIA Cancer Tests to Include Europe, Israel and Africa</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-expands-partnership-with-care-gb-plus-for-proprietary-tbia-cancer-tests-to-include-europe-israel-and-africa</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-expands-partnership-with-care-gb-plus-for-proprietary-tbia-cancer-tests-to-include-europe-israel-and-africa</guid>
      <pubDate>Wed, 16 Sep 2020 13:39:41 GMT</pubDate>
      <description>Todos Medical Expands Partnership with Care G.B. Plus for Proprietary TBIA Cancer Tests to Include Europe, Israel and Africa.</description>
    </item>
    <item>
      <title>Todos Medical Announces August Sales of $1,190,000, Up 100% Compared with July</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-august-sales-of-dollar1190000-up-100percent-compared-with-july</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-august-sales-of-dollar1190000-up-100percent-compared-with-july</guid>
      <pubDate>Thu, 03 Sep 2020 12:04:12 GMT</pubDate>
      <description>Todos Medical Announces August Sales of $1,190,000, Up 100% Compared with July.</description>
    </item>
    <item>
      <title>Todos Medical Announces $23,760,000 Contract for COVID-19 PCR Testing Equipment &amp; Supplies With Wisconsin-based Laboratory</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-dollar23760000-contract-for-covid-19-pcr-testing-equipment-and-supplies-with-wisconsin-based-laboratory</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-dollar23760000-contract-for-covid-19-pcr-testing-equipment-and-supplies-with-wisconsin-based-laboratory</guid>
      <pubDate>Mon, 31 Aug 2020 11:55:41 GMT</pubDate>
      <description>Todos Medical Announces $23,760,000 Contract for COVID-19 PCR Testing Equipment &amp; Supplies With Wisconsin-based Laboratory.</description>
    </item>
    <item>
      <title>Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris Gross as VP of Sales Operations</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-appoints-marsha-fontanive-as-vp-of-sales-and-chris-gross-as-vp-of-sales-operations</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-appoints-marsha-fontanive-as-vp-of-sales-and-chris-gross-as-vp-of-sales-operations</guid>
      <pubDate>Tue, 25 Aug 2020 12:54:11 GMT</pubDate>
      <description>Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris Gross as VP of Sales Operations.</description>
    </item>
    <item>
      <title>Todos Medical Announces $1.2 Million Contract for COVID-19 PCR Testing Equipment &amp; Supplies with Texas-based Laboratory</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-dollar12-million-contract-for-covid-19-pcr-testing-equipment-and-supplies-with-texas-based-laboratory</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-dollar12-million-contract-for-covid-19-pcr-testing-equipment-and-supplies-with-texas-based-laboratory</guid>
      <pubDate>Mon, 24 Aug 2020 11:10:11 GMT</pubDate>
      <description>Todos Medical Announces $1.2 Million Contract for COVID-19 PCR Testing Equipment &amp; Supplies with Texas-based Laboratory.</description>
    </item>
    <item>
      <title>Todos Medical Announces $6,000,000 Contract for COVID-19 PCR Testing Equipment &amp; Supplies with New York-based Laboratory</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-dollar6000000-contract-for-covid-19-pcr-testing-equipment-and-supplies-with-new-york-based-laboratory</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-dollar6000000-contract-for-covid-19-pcr-testing-equipment-and-supplies-with-new-york-based-laboratory</guid>
      <pubDate>Fri, 21 Aug 2020 12:54:41 GMT</pubDate>
      <description>Todos Medical Announces $6,000,000 Contract for COVID-19 PCR Testing Equipment &amp; Supplies with New York-based Laboratory.</description>
    </item>
    <item>
      <title>Todos Medical Announces Positive Proof-of-Concept Data for Novel 10-Minute Point-of-Care Saliva-based Test Detecting Active SARS-CoV-2 Infection</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-positive-proof-of-concept-data-for-novel-10-minute-point-of-care-saliva-based-test-detecting-active-sars-cov-2-infection</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-positive-proof-of-concept-data-for-novel-10-minute-point-of-care-saliva-based-test-detecting-active-sars-cov-2-infection</guid>
      <pubDate>Mon, 17 Aug 2020 15:44:45 GMT</pubDate>
      <description>Todos Medical Announces Positive Proof-of-Concept Data for Novel 10-Minute Point-of-Care Saliva-based Test Detecting Active SARS-CoV-2 Infection.</description>
    </item>
    <item>
      <title>Todos Medical Acquires Distribution Rights to SARS-CoV-2 Rapid Point-of-Care Antigen Test and Rapid Point-of-Care PCR Test</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-acquires-distribution-rights-to-sars-cov-2-rapid-point-of-care-antigen-test-and-rapid-point-of-care-pcr-test</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-acquires-distribution-rights-to-sars-cov-2-rapid-point-of-care-antigen-test-and-rapid-point-of-care-pcr-test</guid>
      <pubDate>Fri, 14 Aug 2020 12:21:11 GMT</pubDate>
      <description>Todos Medical Acquires Distribution Rights to SARS-CoV-2 Rapid Point-of-Care Antigen Test and Rapid Point-of-Care PCR Test.</description>
    </item>
    <item>
      <title>UPDATE: Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/update-todos-medical-announces-common-stock-purchase-agreement-with-lincoln-park-capital-fund-llc</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/update-todos-medical-announces-common-stock-purchase-agreement-with-lincoln-park-capital-fund-llc</guid>
      <pubDate>Mon, 10 Aug 2020 22:58:40 GMT</pubDate>
      <description>UPDATE: Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC.</description>
    </item>
    <item>
      <title>Todos Medical Announces July Sales of COVID-19 Tests</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-july-sales-of-covid-19-tests</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-july-sales-of-covid-19-tests</guid>
      <pubDate>Fri, 07 Aug 2020 13:17:11 GMT</pubDate>
      <description>Todos Medical Announces July Sales of COVID-19 Tests.</description>
    </item>
    <item>
      <title>Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-common-stock-purchase-agreement-with-lincoln-park-capital-fund-llc</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-announces-common-stock-purchase-agreement-with-lincoln-park-capital-fund-llc</guid>
      <pubDate>Thu, 06 Aug 2020 11:45:41 GMT</pubDate>
      <description>Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC.</description>
    </item>
    <item>
      <title>Todos Medical Appoints Dr. Jorge Leon as Consulting Chief Medical and Scientific Officer of Infectious Disease and Oncology</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-appoints-dr-jorge-leon-as-consulting-chief-medical-and-scientific-officer-of-infectious-disease-and-oncology</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-appoints-dr-jorge-leon-as-consulting-chief-medical-and-scientific-officer-of-infectious-disease-and-oncology</guid>
      <pubDate>Tue, 04 Aug 2020 13:23:41 GMT</pubDate>
      <description>Todos Medical Appoints Dr. Jorge Leon as Consulting Chief Medical and Scientific Officer of Infectious Disease and Oncology.</description>
    </item>
    <item>
      <title>Pathnova Laboratories (PATHNOVA) Enters into Partnership to Commercialize Todos Medicals COVID-19 and Breast Cancer Tests in Singapore</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/pathnova-laboratories-pathnova-enters-into-partnership-to-commercialize-todos-medicals-covid-19-and-breast-cancer-tests-in-singapore</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/pathnova-laboratories-pathnova-enters-into-partnership-to-commercialize-todos-medicals-covid-19-and-breast-cancer-tests-in-singapore</guid>
      <pubDate>Mon, 03 Aug 2020 11:24:14 GMT</pubDate>
      <description>Pathnova Laboratories (PATHNOVA) Enters into Partnership to Commercialize Todos Medicals COVID-19 and Breast Cancer Tests in Singapore.</description>
    </item>
    <item>
      <title>Todos Medical Completes Acquisition of Breakthrough Diagnostics, Gains Full Rights to the Alzheimer’s Blood Diagnostic LymPro™ Test from Amarantus</title>
      <link>https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-completes-acquisition-of-breakthrough-diagnostics-gains-full-rights-to-the-alzheimers-blood-diagnostic-lymprotm-test-from-amarantus</link>
      <guid isPermaLink="true">https://6ix.com/company/amarantus-bioscience-holdings-inc/news/todos-medical-completes-acquisition-of-breakthrough-diagnostics-gains-full-rights-to-the-alzheimers-blood-diagnostic-lymprotm-test-from-amarantus</guid>
      <pubDate>Tue, 28 Jul 2020 21:33:41 GMT</pubDate>
      <description>Todos Medical Completes Acquisition of Breakthrough Diagnostics, Gains Full Rights to the Alzheimer’s Blood Diagnostic LymPro™ Test from Amarantus.</description>
    </item>
  </channel>
</rss>